← All organizations
Highest phase reached
Phase 3
First clinical trial
Dec 1, 2014Last known activity
Mar 15, 2024
Timeline
2000s
- Jun 1, 2004
Anavex Life Sciences Corp.— Founded
Drugs by trial phase (3 distinct, 12 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (22)
- NCT06245213Lead sponsorPhase 2Mar 15, 2024
- NCT06245213Sponsor investigatorPhase 2Mar 15, 2024
- NCT04928703CollaboratorEarly Phase 1Sep 1, 2021
- NCT04442945CollaboratorPhase 1Jul 3, 2020
- NCT04442945Lead sponsorPhase 1Jul 3, 2020
- NCT04304482CollaboratorPhase 2/Phase 3Apr 30, 2020
- NCT04304482Lead sponsorPhase 2/Phase 3Apr 30, 2020
- NCT04304482CollaboratorPhase 2/Phase 3Apr 30, 2020
- NCT04314934CollaboratorPhase 2/Phase 3Oct 10, 2019
- NCT04575259Lead sponsorPhase 2Oct 10, 2019
- NCT04575259CollaboratorPhase 2Oct 10, 2019
- NCT04575259CollaboratorPhase 2Oct 10, 2019
- NCT04314934Lead sponsorPhase 2/Phase 3Oct 10, 2019
- NCT04314934CollaboratorPhase 2/Phase 3Oct 10, 2019
- NCT03941444Lead sponsorPhase 2May 6, 2019
Details
- Founded
- New York, NY, US Jun 1, 2004
- Last known activity
- Mar 15, 2024